Online Automated Self-Hypnosis Program

Not Recruiting

Trial ID: NCT03931772


After developing professional quality materials (audio) for an affordable automated self-hypnosis intervention program for facilitating smoking cessation, stress and pain reduction, researchers aim to gain qualitative reviews of this program, and test its initial feasibility and effects on smoking cessation and reduction in pain and stress. In addition, this study seeks to determine whether higher hypnotizability, as measured by the Hypnotic Induction Profile (assessed at baseline), is a moderator of improved outcome in these conditions.

Official Title

Pilot Study Evaluating the Feasibility and Effects of an Innovative Automated Hypnosis Intervention for Smoking Cessation and Pain and Stress Reduction

Stanford Investigator(s)

David Spiegel
David Spiegel

Jack, Lulu and Sam Willson Professor of Medicine


Inclusion/Exclusion criteria for the three arms, with exceptions noted below:

Inclusion Criteria:

   - 18 years or older

   - Able to read and understand English

   - For the smokers, desire to quit smoking (specifically, report a motivation of ≥ 5 out
   of 10 to quit smoking on a 10-point Likert-type scale), and report being a daily
   smoker for at least one year, smoking an average ≥ 5 cigarettes per day

   - For the pain group, report suffering from chronic pain syndromes, such as fibromyalgia
   or chronic low back pain

   - For the stress group, report experiencing moderate to extreme stress or anxiety in the
   past month

   - Having access to wireless internet connection or mobile data

Exclusion Criteria:

   - Meeting criteria for drug abuse, including use of dissociative anesthetics,
   hallucinogens, opioids, cocaine, or amphetamine within the last 3 months

   - Severe psychiatric or structural brain disease (i.e. psychosis, stroke with functional
   impairment, dementia) or current/recent risk to self

   - Hearing impairment that would impede ability to listen the auditory intervention

   - Major illnesses impacting the study results

   - For smokers, currently taking Wellbutrin, Chantix, or other pharmacological smoking
   cessation aids that could confound results of the study


behavioral: Automated Self-Hypnosis

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
David Spiegel